Consumer Health Cancer / Immunology

Gene Solutions' multi-cancer early detection shows promise in Southeast Asia's biotech industry.

Circulating tumor DNA, or cell-free tumor DNA (ctDNA) assay is based on detecting the appearance of ctDNA in blood. This method is sometimes called Liquid ...

 April 26, 2023 | News

SCG Cell Therapy to Highlight Promising Antitumor and Antiviral Activities of SCG101 in Treating HBV-Related Hepatocellular Carcinoma at ISCT

"These exciting new data being presented at ISCT continue to reinforce the potential for viral antigen specific TCR-T product to effectively treat infectio...

 April 24, 2023 | News

CARsgen's CT041 receives IND clearance from NMPA for pancreatic cancer therapy.

Dr Raffaele Baffa, Chief Medical Officer of CARsgen, commented that "We are glad to receive the IND clearance from NMPA for the adjuvant treatment of ...

 April 20, 2023 | News

Samyang Holdings partners with LG Chem for innovative cancer therapeutics.

Samyang Holdings and LG Chem have announced their recent execution of strategic partnership agreement on Thursday, April 20th, for development of nove...

 April 20, 2023 | News

Anixa Biosciences and Cleveland Clinic Present Positive Data for Phase 1 Study of Breast Cancer Vaccine

 Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer  announced that Clev...

 April 18, 2023 | News

BioSenic Granted Key European Patent for Therapeutic Development in Cancer and Immune Diseases

BioSenic’s new formulation lowers the dosage of arsenic trioxide by combining it with copper salts to ma...

 April 18, 2023 | News

Ascentage Pharma's Three Studies Highlight New Potential Indications

  "The data we presented at this year's AACR Annual Meeting highlight the three drug candidates' potential for clinical development and promising syn...

 April 18, 2023 | News

Roche's Tecentriq plus Avastin Reduces Cancer Return Risk in Phase III Liver Cancer Study

In the first-ever positive Phase III trial in the adjuvant hepatocellular carcinoma (HCC) setting, Tecentriq plus Avastin reduced the...

 April 17, 2023 | News

ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients

"We at ImmunOs are very satisfied with the work done by ProBioGen. We highly appreciate the collaborative partnership with ProBioGen and the team's dedicat...

 April 13, 2023 | News

Partnership agreement to commercialize new anti-PD1 antibody in Australia and Southeast Asia signed by Specialised Therapeutics

The therapy ANNIKO® (penpulimab) is an anti-PD1 monoclonal antibody currently under regulatory review by the US FDA for nasopharyngeal carcinoma &...

 April 12, 2023 | News

BGI Global's Colorectal Cancer Survey uncovers gaps in awareness and concerns over affordability

This inaugural report seeks to better understand the global state of CRC awareness, as well as attitudes and actions towards CRC screening for average risk...

 April 07, 2023 | News

Chula Develops CAR T-Cell Therapy for Thai Lymphoma Patients

Chulalongkorn University and the Faculty of Medicine, Chulalongkorn University, organized the 17th Chula the Impact on "CAR T-Cell Canc...

 April 06, 2023 | News

Roche Diagnostics India Unveils #BeYourOwnShero Campaign to Educate Women About Cervical Cancer Prevention

Cervical Cancer is India’s second most common cancer, affecting more than 1.23 lakh women each year. Around 77,000 Indian women die of the disease. D...

 April 05, 2023 | News

Pfizer Invests $43 Billion to Battle Cancer

Pfizer to acquire Seagen for $229 per Seagen share in cash, for a total enterprise value of approximately $43 billion Proposed combination enhances Pfiz...

 March 14, 2023 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close